The Alabama Care Plan: Assessing the Impact of Regional Care Organizations on Diabetes Outcomes in a Sample of Alabama Medicaid Recipients

阿拉巴马州护理计划:评估区域护理组织对阿拉巴马州医疗补助接受者样本中糖尿病结果的影响

基本信息

项目摘要

 DESCRIPTION (provided by applicant):Despite advances in the scientific knowledge related to diabetes prevention and management, diabetes prevalence, complications, and costs continues to rise. A majority of the dollars that go towards diabetes care are spent on Emergency Department visits, hospitalizations, and the management of diabetes complications. Changing the trajectory of the diabetes epidemic in the United States may require a fundamentally new approach to chronic disease management and reimbursement that emphasizes disease prevention and management. Accountable Care Organizations (ACOs) could be such an approach. Under this model, an organization is charged with the care of a population, receives a capitated payment and may be eligible for either a share of any savings achieved and/or at risk for a portion of any spending over the set target. As such, ACOs have been proposed as a means to simultaneously improve population health and reduce health care costs. The Alabama Medicaid program is undergoing a major transformation from a traditional fee for service model to the establishment of ACOs (referred to in Alabama as RCOs or Regional Care Organizations). The Alabama Care Plan, one of 6 probationary RCOs, will assume care for over 70,000 Medicaid recipients in Region B, 11% of whom have diabetes. In April 2015, VIVA Health, a local managed care organization and the lead entity in the Alabama Care Plan, began creating care coordination teams that will work with individuals' current health care providers to comprise a larger "health home." This phased transition provides a unique opportunity for us to assess the impact of policy change related to reimbursement and the delivery of health care as it relates to diabetes. With this proposal, investigators will conduct a rigorous evaluation of the impact of this transition on outcomes in three dimensions: health of a population, experience of care, and per capita cost. The specific aims are: 1. To examine changes in diabetes related population health measures, including glycemic control (HbA1c) and indicators of diabetes care (quarterly HbA1c, annual eye exam); 2. To examine patient experience of care using a telephone-administered survey and qualitative interviews with a subset of individuals with type 2 diabetes enrolled in the Health Home; and 3.To examine changes in health care utilization and overall cost effectiveness of the newly implemented RCO and Health Home compared to diabetes care before RCO implementation. Using Medicaid data beginning in 2010 through 2019, investigators will conduct interrupted time series analyses of data from enrollees within Region B and difference-in- differences analyses to compare changes over time in Region B with changes over time in 3 southern, non- ACO states. The multidisciplinary team of investigators has expertise in diabetes research, use of CMS data, survey administration and qualitative methods. Alabama has the highest rate of diabetes in the United States. As such, this study could have important local and national policy implications for new approaches to diabetes management.
 描述(由适用提供):尽管与糖尿病预防和管理有关的科学知识取得了进步,但糖尿病患病率,并发症和成本仍在继续上升。用于糖尿病护理的大部分钱用于急诊就诊,住院和糖尿病并发症的管理。改变美国糖尿病流行的轨迹可能需要一种从根本上进行慢性病管理和报销的新方法,以强调预防疾病和管理。负责任的护理组织(ACO)可能是一种方法。在此模型下,组织被控以照顾人口,获得了大写的付款,并且可能有资格获得所获得的任何储蓄的一部分和/或面临于设定目标上任何支出的一部分风险。因此,已经提出了ACO作为简单改善人口健康并降低医疗保健成本的一种手段。阿拉巴马州医疗补助计划正在从传统的服务模型费用到建立ACO(在阿拉巴马州称为RCOS或区域护理组织)的重大转变。阿拉巴马州的6个试用RCO之一,将为B地区的70,000多名医疗补助接受者提供护理,其中11%患有糖尿病。 2015年4月,当地托管护理组织和阿拉巴马州护理计划的主要实体Viva Health开始创建护理协调团队,该团队将与个人当前的医疗保健提供者合作,以组成更大的“健康之家”。这种分阶段的过渡为我们提供了一个独特的机会,可以评估与报销相关的政策变更影响以及与糖尿病有关的医疗保健的影响。通过此提案,调查人员将进行 严格评估这种过渡对三个维度结果的影响:人口的健康,护理经验和人均成本。具体目的是:1。检查糖尿病相关人群健康指标的变化,包括血糖控制(HBA1C)和糖尿病护理指标(季度HBA1C,年度眼科检查); 2。使用电话管理的调查和与卫生所住房中2型糖尿病的一个人的一部分进行定性访谈来检查患者的护理经验; 3.与RCO实施前相比,与糖尿病护理相比,新实施的RCO和健康之家的医疗保健利用率和总体成本效益的变化。使用从2010年到2019年开始的医疗补助数据,研究人员将对B区域内注册的数据进行中断的时间序列分析,并进行差异分析,以比较B区域B的变化与3个南部,非ACO状态的随时间变化。研究人员的多学科团队拥有糖尿病研究,使用CMS数据,调查管理和定性方法的专家。阿拉巴马州的糖尿病发生率最高。因此,这项研究可能对糖尿病管理的新方法具有重要的本地和国家政策影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrea L Cherrington其他文献

Andrea L Cherrington的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrea L Cherrington', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10681009
  • 财政年份:
    2021
  • 资助金额:
    $ 47.75万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10437091
  • 财政年份:
    2021
  • 资助金额:
    $ 47.75万
  • 项目类别:
The Alabama Cardiovascular Cooperative: Supporting Cardiovascular Risk Reduction in Primary Care
阿拉巴马州心血管合作社:支持初级保健中降低心血管风险
  • 批准号:
    10542719
  • 财政年份:
    2021
  • 资助金额:
    $ 47.75万
  • 项目类别:
The Alabama Cardiovascular Cooperative: Supporting Cardiovascular Risk Reduction in Primary Care
阿拉巴马州心血管合作社:支持初级保健中降低心血管风险
  • 批准号:
    10323063
  • 财政年份:
    2021
  • 资助金额:
    $ 47.75万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10681020
  • 财政年份:
    2021
  • 资助金额:
    $ 47.75万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10676260
  • 财政年份:
    2021
  • 资助金额:
    $ 47.75万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10494284
  • 财政年份:
    2021
  • 资助金额:
    $ 47.75万
  • 项目类别:
Collaboration to Improve Blood Pressure in the US Black Belt- Addressing the Triple Threat
合作改善美国黑带血压——应对三重威胁
  • 批准号:
    10191671
  • 财政年份:
    2020
  • 资助金额:
    $ 47.75万
  • 项目类别:
The Alabama Care Plan: Assessing the Impact of Regional Care Organizations on Diabetes Outcomes in a Sample of Alabama Medicaid Recipients
阿拉巴马州护理计划:评估区域护理组织对阿拉巴马州医疗补助接受者样本中糖尿病结果的影响
  • 批准号:
    9889955
  • 财政年份:
    2016
  • 资助金额:
    $ 47.75万
  • 项目类别:
The Alabama Care Plan: Assessing the Impact of Regional Care Organizations on Diabetes Outcomes in a Sample of Alabama Medicaid Recipients
阿拉巴马州护理计划:评估区域护理组织对阿拉巴马州医疗补助接受者样本中糖尿病结果的影响
  • 批准号:
    9211324
  • 财政年份:
    2016
  • 资助金额:
    $ 47.75万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

A comparative evaluation of overdose prevention programs in New York City and Rhode Island
纽约市和罗德岛州药物过量预防计划的比较评估
  • 批准号:
    10629749
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Mixed methods examination of warning signs within 24 hours of suicide attempt in hospitalized adults
住院成人自杀未遂 24 小时内警告信号的混合方法检查
  • 批准号:
    10710712
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
The Social-Medical Network: Using a Network Approach to Explore the Integration of Informal and Formal Care Networks of Older Adults
社会医疗网络:利用网络方法探索老年人非正式和正式护理网络的整合
  • 批准号:
    10724756
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Feasibility of a care team-focused action plan to improve quality of care for children and adolescents with inflammatory bowel disease
以护理团队为重点的行动计划的可行性,以提高炎症性肠病儿童和青少年的护理质量
  • 批准号:
    10724900
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
  • 批准号:
    10749448
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了